Production (Stage)
Greenwich LifeSciences, Inc.
GLSI
$9.20
-$0.27-2.85%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 2.75M | 4.09M | 5.82M | 7.22M | 5.51M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 2.75M | 4.09M | 5.82M | 7.22M | 5.51M |
|
|
|||||
| Total Current Assets | 2.75M | 4.09M | 5.82M | 7.22M | 5.51M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 900.00 | 1.80K | 2.70K | 3.60K | 4.50K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 2.75M | 4.09M | 5.83M | 7.23M | 5.51M |
|
|
|||||
| Total Accounts Payable | 827.00K | 956.70K | 553.90K | 1.11M | 125.70K |
| Total Accrued Expenses | 611.50K | 603.00K | 288.50K | 238.60K | 263.90K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 1.44M | 1.56M | 842.40K | 1.35M | 389.60K |
|
|
|||||
| Total Current Liabilities | 1.44M | 1.56M | 842.40K | 1.35M | 389.60K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 1.44M | 1.56M | 842.40K | 1.35M | 389.60K |
|
|
|||||
| Common Stock & APIC | 70.72M | 68.69M | 63.10M | 61.32M | 57.96M |
| Retained Earnings | -69.41M | -66.15M | -58.11M | -55.44M | -52.84M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 1.31M | 2.53M | 4.98M | 5.88M | 5.12M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1.31M | 2.53M | 4.98M | 5.88M | 5.12M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1.31M | 2.53M | 4.98M | 5.88M | 5.12M |
|
|
|||||